Cargando…

Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma

BACKGROUND: It has been shown that heat shock-related 70-kDa protein 2 (HSPA2), a member of the HSP70 family of heat shock proteins, is important for cancer cell growth and metastasis. However, the status of HSPA2 expression and its prognostic significance in pancreatic cancer remain unknown. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Gao, Hongli, Liu, Chengli, Kong, Yalin, Wang, Cheng, Zhang, Hongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383074/
https://www.ncbi.nlm.nih.gov/pubmed/25890028
http://dx.doi.org/10.1186/s13000-015-0253-9
_version_ 1782364675020685312
author Zhang, Hui
Gao, Hongli
Liu, Chengli
Kong, Yalin
Wang, Cheng
Zhang, Hongyi
author_facet Zhang, Hui
Gao, Hongli
Liu, Chengli
Kong, Yalin
Wang, Cheng
Zhang, Hongyi
author_sort Zhang, Hui
collection PubMed
description BACKGROUND: It has been shown that heat shock-related 70-kDa protein 2 (HSPA2), a member of the HSP70 family of heat shock proteins, is important for cancer cell growth and metastasis. However, the status of HSPA2 expression and its prognostic significance in pancreatic cancer remain unknown. METHODS: Quantitative reverse transcriptase ploymerase chain reaction (qRT-PCR) was applied to examine HSPA2 messenger RNA (mRNA) expression in 104 pairs of pancreatic cancer tissues and adjacent noncancerous tissues. Statistical analyses were applied to evaluate the diagnostic value and associations of HSPA2 expression with clinicopathological characteristics. RESULTS: HSPA2 mRNA was significantly overexpressed in pancreatic cancer tissues (3.9 ± 0.8) than in adjacent normal tissues (1.1 ± 0.4) (P < 0.001). Clinicopathological analysis showed that HSPA2 expression was significantly correlated with tumor size (P = 0.024), histological differentiation (P = 0.012), TNM stage (P = 0.006), lymph node metastasis (P = 0.043) and serum CA19-9 level (P = 0.046). Moreover, patients with higher HSPA2 expression levels had shorter overall survival time than those with lower HSPA2 expression levels (P = 0.019). Furthermore, Cox regression analyses showed that HSPA2 expression was an independent predictor of overall survival (P = 0.011). CONCLUSIONS: Our results suggest that overexpression of HSPA2 in pancreatic cancer is associated with aggressive progression and poor prognosis and that HSPA2 may be served as a prognostic marker. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5988744821527257.
format Online
Article
Text
id pubmed-4383074
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43830742015-04-03 Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma Zhang, Hui Gao, Hongli Liu, Chengli Kong, Yalin Wang, Cheng Zhang, Hongyi Diagn Pathol Research BACKGROUND: It has been shown that heat shock-related 70-kDa protein 2 (HSPA2), a member of the HSP70 family of heat shock proteins, is important for cancer cell growth and metastasis. However, the status of HSPA2 expression and its prognostic significance in pancreatic cancer remain unknown. METHODS: Quantitative reverse transcriptase ploymerase chain reaction (qRT-PCR) was applied to examine HSPA2 messenger RNA (mRNA) expression in 104 pairs of pancreatic cancer tissues and adjacent noncancerous tissues. Statistical analyses were applied to evaluate the diagnostic value and associations of HSPA2 expression with clinicopathological characteristics. RESULTS: HSPA2 mRNA was significantly overexpressed in pancreatic cancer tissues (3.9 ± 0.8) than in adjacent normal tissues (1.1 ± 0.4) (P < 0.001). Clinicopathological analysis showed that HSPA2 expression was significantly correlated with tumor size (P = 0.024), histological differentiation (P = 0.012), TNM stage (P = 0.006), lymph node metastasis (P = 0.043) and serum CA19-9 level (P = 0.046). Moreover, patients with higher HSPA2 expression levels had shorter overall survival time than those with lower HSPA2 expression levels (P = 0.019). Furthermore, Cox regression analyses showed that HSPA2 expression was an independent predictor of overall survival (P = 0.011). CONCLUSIONS: Our results suggest that overexpression of HSPA2 in pancreatic cancer is associated with aggressive progression and poor prognosis and that HSPA2 may be served as a prognostic marker. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5988744821527257. BioMed Central 2015-03-27 /pmc/articles/PMC4383074/ /pubmed/25890028 http://dx.doi.org/10.1186/s13000-015-0253-9 Text en © Zhang et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Hui
Gao, Hongli
Liu, Chengli
Kong, Yalin
Wang, Cheng
Zhang, Hongyi
Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
title Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
title_full Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
title_fullStr Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
title_full_unstemmed Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
title_short Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
title_sort expression and clinical significance of hspa2 in pancreatic ductal adenocarcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383074/
https://www.ncbi.nlm.nih.gov/pubmed/25890028
http://dx.doi.org/10.1186/s13000-015-0253-9
work_keys_str_mv AT zhanghui expressionandclinicalsignificanceofhspa2inpancreaticductaladenocarcinoma
AT gaohongli expressionandclinicalsignificanceofhspa2inpancreaticductaladenocarcinoma
AT liuchengli expressionandclinicalsignificanceofhspa2inpancreaticductaladenocarcinoma
AT kongyalin expressionandclinicalsignificanceofhspa2inpancreaticductaladenocarcinoma
AT wangcheng expressionandclinicalsignificanceofhspa2inpancreaticductaladenocarcinoma
AT zhanghongyi expressionandclinicalsignificanceofhspa2inpancreaticductaladenocarcinoma